Literature DB >> 19242678

The effects of yohimbine and amphetamine on fear expression and extinction in rats.

Devin Mueller1, Lening A Olivera-Figueroa, Daniel S Pine, Gregory J Quirk.   

Abstract

RATIONALE: Psychostimulants, such as yohimbine and amphetamine, can enhance learning and memory. Extinction of conditioned fear involves new learning, so we asked whether psychostimulants could enhance this learning. Previous work suggests that yohimbine facilitates extinction, using freezing as a fear measure. However, psychostimulant-induced alterations in locomotion can confound freezing measurements. Furthermore, the effects of amphetamine on fear extinction have never been examined.
OBJECTIVE: We evaluated the effectiveness of yohimbine and amphetamine in enhancing fear extinction. In addition to freezing, we measured bar-press suppression, which is less sensitive to changes in locomotion. We asked: Do psychostimulants reduce fear during extinction training when drug is present? Does learning extinction with psychostimulants result in better extinction retention?
MATERIALS AND METHODS: Rats received fear conditioning on day 1 followed by partial extinction training on days 2 and 3. Yohimbine (1.0, 2.0, or 5.0 mg/kg, i.p.), amphetamine (1.0 mg/kg, i.p.), or vehicle were injected prior to extinction on day 2.
RESULTS: Yohimbine dose-dependently reduced freezing during extinction training on day 2, whereas bar-press suppression was reduced at the highest dose only. When tested drug-free, yohimbine-treated rats showed equivalent levels of freezing and suppression to controls. Amphetamine also decreased freezing during extinction, but did not decrease suppression. During the drug-free test, there was no difference between amphetamine-treated rats and controls in either measure.
CONCLUSIONS: Although yohimbine and amphetamine are capable of decreasing freezing, neither drug strengthened retention of fear extinction. Based on these rodent findings, psychostimulants may not be suitable adjuncts to extinction-based therapies for the treatment of anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242678      PMCID: PMC2692542          DOI: 10.1007/s00213-009-1491-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis.

Authors:  T B Borowski; L Kokkinidis
Journal:  Behav Neurosci       Date:  1998-08       Impact factor: 1.912

3.  Stimulation of the noradrenergic system enhances and blockade reduces memory for emotional material in man.

Authors:  R E O'Carroll; E Drysdale; L Cahill; P Shajahan; K P Ebmeier
Journal:  Psychol Med       Date:  1999-09       Impact factor: 7.723

4.  Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites.

Authors:  A L Johnston; S E File
Journal:  Pharmacol Biochem Behav       Date:  1989-01       Impact factor: 3.533

5.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

6.  Adrenergic transmission facilitates extinction of conditional fear in mice.

Authors:  Christopher K Cain; Ashley M Blouin; Mark Barad
Journal:  Learn Mem       Date:  2004 Mar-Apr       Impact factor: 2.460

Review 7.  Limits of habituation and extinction: implications for relapse prevention programs in addictions.

Authors:  A Tobeña; A Fernández-Teruel; R M Escorihuela; J F Núñez; A Zapata; P Ferré; R Sánchez
Journal:  Drug Alcohol Depend       Date:  1993-05       Impact factor: 4.492

8.  Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice.

Authors:  Suzanne C Wood; Stephan G Anagnostaras
Journal:  Psychopharmacology (Berl)       Date:  2008-05-15       Impact factor: 4.530

9.  Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors.

Authors:  Sandro Fenu; Gaetano Di Chiara
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

10.  Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain.

Authors:  Kathryn Hefner; Nigel Whittle; Jaynann Juhasz; Maxine Norcross; Rose-Marie Karlsson; Lisa M Saksida; Timothy J Bussey; Nicolas Singewald; Andrew Holmes
Journal:  J Neurosci       Date:  2008-08-06       Impact factor: 6.167

View more
  21 in total

1.  Deepened extinction following compound stimulus presentation: noradrenergic modulation.

Authors:  Patricia H Janak; Laura H Corbit
Journal:  Learn Mem       Date:  2010-12-14       Impact factor: 2.460

Review 2.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 3.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 4.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Posttraumatic Stress Disorder: an integrated overview and neurobiological rationale for pharmacology.

Authors:  Benjamin Kelmendi; Thomas G Adams; Steven Southwick; Chadi G Abdallah; John H Krystal
Journal:  Clin Psychol (New York)       Date:  2017-07-18

6.  3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.

Authors:  Holly S Hake; Jazmyne K P Davis; River R Wood; Margaret K Tanner; Esteban C Loetz; Anais Sanchez; Mykola Ostrovskyy; Erik B Oleson; Jim Grigsby; Rick Doblin; Benjamin N Greenwood
Journal:  Physiol Behav       Date:  2018-12-04

Review 7.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 8.  Cognitive enhancers for facilitating drug cue extinction: insights from animal models.

Authors:  Bríd Áine Nic Dhonnchadha; Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

9.  Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear.

Authors:  Demetrio Sierra-Mercado; Nancy Padilla-Coreano; Gregory J Quirk
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

10.  Amphetamine and extinction of cued fear.

Authors:  Stephanie A Carmack; Suzanne C Wood; Stephan G Anagnostaras
Journal:  Neurosci Lett       Date:  2009-10-21       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.